REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 94 filers reported holding REATA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,616,434 | -77.2% | 84,508 | -79.6% | 0.02% | -78.8% |
| Q1 2023 | $37,727,619 | +383.6% | 414,954 | +102.1% | 0.08% | +344.4% |
| Q4 2022 | $7,800,945 | +2483.1% | 205,342 | +1611.2% | 0.02% | +1700.0% |
| Q3 2022 | $302,000 | -76.8% | 12,000 | +14.1% | 0.00% | -85.7% |
| Q4 2020 | $1,300,000 | +92.6% | 10,516 | +51.9% | 0.01% | +75.0% |
| Q3 2020 | $675,000 | +211.1% | 6,925 | -34.7% | 0.00% | -55.6% |
| Q1 2018 | $217,000 | – | 10,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |